Amarin stock rides wave of good news

Good news regarding two of Groton-based Amarin Corp. PLC's patent applications pushed the company's stock price higher last week.

According to Amarin, the U.S. Patent & Trademark Office issued a notice this week that a patent was forthcoming because of "surprising and unexpected" findings during clinical trials of Vascepa, the company's heart pill.

Amarin's stock price soared from less than $14 a share early in the week to close to $15 shortly after the announcement. Shares settled at $14.78 Friday.

Amarin Chairman and chief executive Joseph Zakrzewski said the patents would be valid until at least 2030 once officially issued.

- Lee Howard

Hide Comments

READER COMMENTS

Loading comments...
Hide Comments